Home Events MSI Testing Changing Treatment Landscape For Colorectal Cancer Patients

MSI Testing Changing Treatment Landscape For Colorectal Cancer Patients

Date

December 06 2021

Time

1:00 pm - 2:30 pm

Speakers

  • Dr David Schaeffer

    Dr. Schaeffer is an associate professor in the Department of Pathology & Laboratory Medicine at University of British
    Columbia and the Head of the Department of Pathology at Vancouver General Hospital (VGH) where he practices as a
    gastrointestinal pathologist. Dr. Schaeffer obtained his medical degree from the Johannes Gutenberg University of Mainz,
    Germany. After a residency program in Anatomical Pathology in Vancouver he completed his gastrointestinal pathology
    fellowship at Mount Sinai Hospital in Toronto. Dr. Schaeffer is a co-director of Pancreas Centre BC and also heads the
    Gastrointestinal Biobank (GIBB) at VGH. He has an active research program focusing predominately on translational research
    in colonic and pancreatic cancer.

  • Dr Sharlene Gill
    Dr Sharlene Gill

    Dr. Sharlene Gill is a Professor of Medicine at the University of GI malignancies at BC Cancer – Vancouver. She received a Bachelors of Science in Pharmacy and an MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Masters of Public Health from the Harvard School of Public Health. In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina. She is actively engaged in education and research, with over 120 peer-reviewed publications and book chapters to her credit. Dr. Gill serves as the Chair of the CCTG GI Site Committee and Chair of the UBC Department of Medicine Mentoring Committee. She is the Editor-in-Chief for Current Oncology and is the President of the Canadian Association of Medical Oncologists.

Objectives

-Review MSI testing in mCRC in Canada
-Discuss MMR and other clinically relevant biomarkers in mCRC
-Discuss reporting of MMR

Co-Developed with